{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T06:24:54Z","timestamp":1773555894037,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":375,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding at Fuwai Hospital, Chinese Academy of Medical Sciences","award":["2023-GSP-GG-26"],"award-info":[{"award-number":["2023-GSP-GG-26"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Research on iron deficiency (ID) in patients with light chain cardiac amyloidosis (AL-CM) has been limited in previous studies. The purpose of this study was to investigate the prevalence and its association with prognosis of ID based on different definitions in patients with AL-CM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Three different ID definitions were applied: (1) serum ferritin concentration of &amp;lt;100 ng\/mL, or 100\u2013299 ng\/mL with transferrin saturation (TSAT) &amp;lt; 20% (according to guidelines on heart failure), (2) TSAT &amp;lt; 20% and (3) serum iron &amp;lt;13 \u03bcmol\/L. The primary outcome measure was all-cause mortality. Prevalence and outcomes of various ID definitions were evaluated among patients diagnosed with AL-CM at Heart Failure Center, Fuwai Hospital between September 2017 and October 2023. Overall, 149 patients were included with a mean age of 60.71 \u00b1 10.11 years, of whom 60 (40.3%) patients were female, 127 (85.2%) patients were in New York Heart Association (NYHA) class III\u2013IV and 136 (91.3%) patients were in the revised Mayo 2012 stage III\u2013IV. Assessments of iron biomarkers revealed the following results: median ferritin levels were 183.68 ng\/mL (interquartile range [IQR] 95.48, 339.01), median TSAT was 21.80% (IQR 16.34, 29.48), and median serum iron was 10.87 \u03bcmol\/L (IQR 7.38, 13.71). Serum iron were highly correlated with TSAT (r = 0.85, P &amp;lt; 0.0001). Depending on the definition used, 63 (42.3%) patients, 61 (40.9%) patients and 105 (70.5%) patients were defined as ID, respectively (P &amp;lt; 0.0001). ID defined by TSAT and serum iron was associated with the primary outcome [hazard ratio (HR) 2.14, 95% confidence interval (CI) 1.36\u20133.37, P &amp;lt; 0.001, and HR 2.16, 95% CI (1.23\u20133.80), P &amp;lt; 0.01], but the same association was not seen with the guideline definition of ID [HR 1.39, 95% CI (0.88\u20132.18), P = 0.158]. In the multivariable model adjusting for age, gender, haemoglobin, and revised 2012 Mayo staging, the predictive value of TSAT &amp;lt; 20% [adjusted HR 2.49, 95% CI (1.54\u20134.05), P &amp;lt; 0.001] and serum iron &amp;lt; 13 \u03bcmol\/L [adjusted HR 2.24, 95% CI (1.23\u20134.09), P &amp;lt; 0.01] remained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Different definitions of ID yield inconsistent results in terms of prevalence and prognosis. ID, as defined by TSAT &amp;lt; 20% or serum iron &amp;lt; 13 \u03bcmol\/L, rather than the guideline definition, emerged as an independent predictor of all-cause mortality in patients with AL-CM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15227","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T02:42:44Z","timestamp":1739241764000},"page":"2134-2147","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and Prognostic Value of Different Iron Deficiency Definitions in Light Chain Cardiac Amyloidosis Patients"],"prefix":"10.1093","volume":"12","author":[{"given":"Xinqing","family":"Li","sequence":"first","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anran","family":"Xin","sequence":"additional","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxi","family":"Wang","sequence":"additional","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) of German Heart Center Charit\u00e9, German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charit\u00e9 Universit\u00e4tsmedizin , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"2026021804263061500_ehf215227-bib-0001","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0002","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00392-018-1344-x","article-title":"Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life","volume":"108","author":"Bekfani","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0003","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0004","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-024-00988-1","article-title":"Iron deficiency and supplementation in heart failure","volume":"21","author":"Lakhal-Littleton","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0005","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0006","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/eurjpc\/zwaa112","article-title":"Prognostic role of transferrin saturation in heart failure patients","volume":"28","author":"Campodonico","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0007","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/ehf2.14265","article-title":"Applicability of new proposed criteria for iron deficiency in Japanese patients with heart failure","volume":"10","author":"Tada","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0008","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2949","article-title":"Prognostic value of three iron deficiency definitions in patients with advanced heart failure","volume":"25","author":"Papadopoulou","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0009","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0010","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0011","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804263061500_ehf215227-bib-0012","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13023-022-02414-6","article-title":"Global epidemiology of amyloid light-chain amyloidosis","volume":"17","author":"Kumar","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2026021804263061500_ehf215227-bib-0013","first-page":"1","article-title":"Cardiac troponin in patients with light chain and transthyretin cardiac amyloidosis: JACC: CardioOncology state-of-the-art review","volume":"6","author":"Michieli","year":"2024","journal-title":"Cardio Oncol"},{"key":"2026021804263061500_ehf215227-bib-0014","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"JCO"},{"key":"2026021804263061500_ehf215227-bib-0015","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin","year":"2021","journal-title":"Circ Res"},{"key":"2026021804263061500_ehf215227-bib-0016","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ehf2.13818","article-title":"Prevalence and determinants of iron deficiency in cardiac amyloidosis","volume":"9","author":"Jobb\u00e9-Duval","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0017","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026021804263061500_ehf215227-bib-0018","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"2026021804263061500_ehf215227-bib-0019","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0020","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065645","article-title":"Markers of iron metabolism and outcomes in patients with heart failure: a systematic review","volume":"24","author":"Dhaliwal","year":"2023","journal-title":"IJMS"},{"key":"2026021804263061500_ehf215227-bib-0021","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/ejhf.2036","article-title":"High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality","volume":"23","author":"Sierpinski","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026021804263061500_ehf215227-bib-0022","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"Van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2026021804263061500_ehf215227-bib-0023","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026021804263061500_ehf215227-bib-0024","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/eurheartj\/ehr504","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study","volume":"34","author":"Comin-Colet","year":"2013","journal-title":"Eur Heart J"},{"key":"2026021804263061500_ehf215227-bib-0025","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026021804263061500_ehf215227-bib-0026","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2026021804263061500_ehf215227-bib-0027","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"2026021804263061500_ehf215227-bib-0028","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41569-023-00951-6","article-title":"Defining iron deficiency in patients with heart failure","volume":"21","author":"Cleland","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026021804263061500_ehf215227-bib-0029","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/2134\/66956177\/eschf_12_3_2134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/2134\/66956177\/eschf_12_3_2134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:26:38Z","timestamp":1771406798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/3\/2134\/8488350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2,8]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15227","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"2024-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}